FAM172A induces S phase arrest of HepG2 cells via Notch 3 Retraction in /10.3892/or.2023.8554

Feng,Zhiqiang; Li,Hongqi; Liu,Shunai; Cheng,Jun; Xiang,Guoan; Zhang,Jinqian

doi:10.3892/or.2013.2235

FAM172A induces S phase arrest of HepG2 cells via Notch 3

Retraction in: /10.3892/or.2023.8554

Authors:
- Zhiqiang Feng
- Hongqi Li
- Shunai Liu
- Jun Cheng
- Guoan Xiang
- Jinqian Zhang
View Affiliations

Affiliations: Department of Hepatobiliary Surgery, Air Force General Hospital of PLA, Beijing 100142, P.R. China, Department of Radiation Oncology, Air Force General Hospital of PLA, Beijing 100142, P.R. China, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China, Department of General Surgery, The Second People's Hospital of Guangdong Province, Guangzhou 510515, P.R. China
Published online on: January 11, 2013 https://doi.org/10.3892/or.2013.2235
Pages: 1154-1160

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Our previous results revealed that FAM172A was significantly downregulated in liver tissue from hepatocellular carcinoma or cirrhotic patients. The present study was designed to elucidate the regulatory role of FAM172A in HepG2 cells. In order to determine the expression of the FAM172A protein, western blot analysis was performed. Confocal laser scanning technique was used to observe the localization of FAM172A in HepG2 cells. Surface plasmon resonance experiments were used to determine the binding activity of FAM172A and active single sugar and Ca2+. The cell cycle progression of HepG2 cells was assessed by flow cytometry. The FAM172A protein was localized in the endoplasmic reticulum of HepG2 cells. This protein was moderately expressed in normal liver tissue, but was significantly decreased in liver tissue of patients with chronic hepatitis B When co-cultured with the FAM172A recombinant protein, HepG2 cells exhibited complete cell cycle arrest in the S phase at a high concentration (100 ng/ml). Proliferation of HepG2 cells treated with the FAM172A recombinant protein was prominently inhibited compared with that of the control cells. Western blot analysis showed that upregulation of Notch 3 and cyclin E may be related with the cell cycle control. Our results indicate that FAM172A may be a novel tumor-suppressor gene, which plays an important role in cell cycle control and tumor cell proliferation. G1/S phase arrest may be mediated, at least partially, by the Notch 3 signaling pathway.

View Figures

View References

1	Beasley RP: Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer. 61:1942–1956. 1998. View Article : Google Scholar
2	Papatheodoridis GV, Lampertico P, Manolakopoulos S and Lok A: Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol. 53:348–356. 2010. View Article : Google Scholar : PubMed/NCBI
3	Fan X, Fang D, Bin D, Xueyong L, Jun C and Hongshan W: Serum levels of surface large envelope protein: prognostic marker for hepatitis B e antigen-negative patients with adefovir dipivoxil treatment. Antivir Ther. 14:1149–1156. 2009. View Article : Google Scholar
4	Wong DK, Yuen MF, Poon RT, Yuen JC, Fung J and Lai CL: Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol. 45:553–559. 2006. View Article : Google Scholar : PubMed/NCBI
5	Barone M, Daniela Spano D, D'Apolito M, Centra M, Lasalandra C, Capasso M, Di Leo A, Volinia S, Arcelli D, Rosso N, Francavilla A, Tiribelli C and Iolascon A: Gene expression analysis in HBV transgenic mouse liver: a model to study early events related to hepatocarcinogenesis. Mol Med. 12:115–123. 2006. View Article : Google Scholar : PubMed/NCBI
6	Ehebauer M, Hayward P and Arias AM: Notch, a universal arbiter of cell fate decisions. Science. 314:1414–1415. 2006. View Article : Google Scholar : PubMed/NCBI
7	Louis AA, Van Eyken P, Haber BA, Hicks C, Weinmaster G, Taub R and Rand EB: Hepatic jagged1 expression studies. Hepatology. 30:1269–1275. 1999. View Article : Google Scholar : PubMed/NCBI
8	Geisler F, Nagl F, Mazur PK, Lee M, Zimber-Strobl U, Strobl LJ, Radtke F, Schmid RM and Siveke JT: Liver-specific inactivation of Notch2, but not Notch1, compromises intrahepatic bile duct development in mice. Hepatology. 48:607–616. 2008. View Article : Google Scholar : PubMed/NCBI
9	Yuan ZR, Kobayashi N and Kohsaka T: Human Jagged 1 mutants cause liver defect in Alagille syndrome by overexpression of hepatocyte growth factor. J Mol Biol. 356:559–568. 2006. View Article : Google Scholar : PubMed/NCBI
10	Nijjar SS, Wallace L, Crosby HA, Hubscher SG and Strain AJ: Altered Notch ligand expression in human liver disease: further evidence for a role of the Notch signaling pathway in hepatic neovascularization and biliary ductular defects. Am J Pathol. 160:1695–1703. 2002. View Article : Google Scholar
11	Gramantieri L, Giovannini C, Lanzi A, Chieco P, Ravaioli M, Venturi A, Grazi GL and Bolondi L: Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. Liver Int. 27:997–1007. 2007. View Article : Google Scholar : PubMed/NCBI
12	Siegel AB, Olsen SK, Magun A and Brown RS Jr: Sorafenib: where do we go from here? Hepatology. 52:360–369. 2012. View Article : Google Scholar : PubMed/NCBI
13	Li GL, Wei HS, Song SJ, Guo J and Cheng J: The effects of angiotensin II on gene expression of hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi. 14:914–919. 2006.(In Chinese).
14	Gutiérrez Gallego R, Haseley SR, van Miegem VF, Vliegenthart JF and Kamerling JP: Identification of carbohydrates binding to lectins by using surface plasmon resonance in combination with HPLC profiling. Glycobiology. 14:373–386. 2004.PubMed/NCBI
15	Chen X, Kintner DB, Luo J, Baba A, Matsuda T and Sun D: Endoplasmic reticulum Ca²⁺ dysregulation and endoplasmic reticulum stress following in vitro neuronal ischemia: role of Na⁺-K⁺-Cl⁻ cotransporter. J Neurochem. 106:1563–1576. 2008.
16	Shuda M, Kondoh N, Imazeki N, Tanaka K, Okada T, Mori K, Hada A, Arai M, Wakatsuki T, Matsubara O, Yamamoto N and Yamamoto M: Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis. J Hepatol. 38:605–614. 2003. View Article : Google Scholar : PubMed/NCBI
17	Arai M, Kondoh N, Imazeki N, Hada A, Hatsuse K, Kimura F, Matsubara O, Mori K, Wakatsuki T and Yamamoto M: Transformation-associated gene regulation by ATF6alpha during hepatocarcinogenesis. FEBS Lett. 580:184–190. 2006. View Article : Google Scholar : PubMed/NCBI
18	Gao J, Song Z, Chen Y, Xia L, Wang J, Fan R, Du R, Zhang F, Hong L, Song J, Zou X, Xu H, Zheng G, Liu J and Fan D: Deregulated expression of Notch receptors in human hepatocellular carcinoma. Dig Liver Dis. 40:114–121. 2008. View Article : Google Scholar : PubMed/NCBI
19	Giovannini C, Lacchini M, Gramantieri L, Chieco P and Bolondi L: Notch3 intracellular domain accumulates in HepG2 cell line. Anticancer Res. 26:2123–2127. 2006.PubMed/NCBI
20	Xu HY, Li BJ, Wang RF and Andersson R: Alterations of Notch/Jagged mRNA and protein expression after partial hepatectomy in rats. Scand J Gastroenterol. 43:1522–1528. 2008. View Article : Google Scholar : PubMed/NCBI
21	Monsalve E, Ruiz-García A, Baladrón V, Ruiz-Hidalgo MJ, Sánchez-Solana B, Rivero S, García-Ramírez JJ, Rubio A, Laborda J and Díaz-Guerra MJ: Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity. Eur J Immunol. 39:2556–2570. 2009. View Article : Google Scholar : PubMed/NCBI
22	Itoh M, Fu L and Tohda S: NF-κB activation induced by Notch ligand stimulation in acute myeloid leukemia cells. Oncol Rep. 22:631–634. 2009.
23	Nevzorova YA, Tschaharganeh D, Gassler N, Geng Y, Weiskirchen R, Sicinski P, Trautwein C and Liedtke C: Aberrant cell cycle progression and endoreplication in regenerating livers of mice that lack a single E-type cyclin. Gastroenterology. 137:691–703. 2009. View Article : Google Scholar : PubMed/NCBI
24	Cho JW, Lee KS and Kim CW: Curcumin attenuates the expression of IL-1β, IL-6, and TNF-α as well as cyclin E in TNF-α-treated HaCaT cells; NF-κB and MAPKs as potential upstream targets. Int J Mol Med. 19:469–474. 2007.
25	Morga E, Mouad-Amazzal L, Felten P, Heurtaux T, Moro M, Michelucci A, Gabel S, Grandbarbe L and Heuschling P: Jagged1 regulates the activation of astrocytes via modulation of NFkappaB and JAK/STAT/SOCS pathways. Glia. 57:1741–1753. 2009. View Article : Google Scholar : PubMed/NCBI
26	Feng B, Cheng S, Hsia CY, King LB, Monroe JG and Liou HC: NF-kappaB inducible genes BCL-X and cyclin E promote immature B-cell proliferation and survival. Cell Immunol. 232:9–20. 2004. View Article : Google Scholar : PubMed/NCBI
27	Bharti AC, Takada Y, Shishodia S and Aggarwal BB: Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism. J Biol Chem. 279:6065–6076. 2004. View Article : Google Scholar
28	Chen E and Li CC: Association of Cdk2/cyclin E and NF-kappa B complexes at G1/S phase. Biochem Biophys Res Commun. 249:728–734. 1998. View Article : Google Scholar : PubMed/NCBI
29	Pujol MJ, Jaime M, Serratosa J, Jaumot M, Agell N and Bachs O: Differential association of p21Cip1 and p27Kip1 with cyclin E-CDK2 during rat liver regeneration. J Hepatol. 33:266–274. 2000. View Article : Google Scholar : PubMed/NCBI
30	Koroxenidou L, Ohlson LC and Porsch Hällström I: Long-term 17alpha-ethinyl estradiol treatment decreases cyclin E and cdk2 expression, reduces cdk2 kinase activity and inhibits S phase entry in regenerating rat liver. J Hepatol. 43:478–484. 2005. View Article : Google Scholar : PubMed/NCBI
31	Lin SS, Huang HP, Yang JS, Wu JY, Hsia TC, Lin CC, Lin CW, Kuo CL, Gibson Wood W and Chung JG: DNA damage and endoplasmic reticulum stress mediated curcumin-induced cell cycle arrest and apoptosis in human lung carcinoma A-549 cells through the activation of caspase cascade- and mitochondrial-dependent pathway. Cancer Lett. 272:77–90. 2008. View Article : Google Scholar
32	Derkx PM and Madrid SM: The foldase CYPB is a component of the secretory pathway of Aspergillus niger and contains the endoplasmic reticulum retention signal HEEL. Mol Genet Genomics. 266:537–545. 2001. View Article : Google Scholar : PubMed/NCBI